Research & Collaboration

We partner with pioneering scientists, researchers, educators, Universities, tech innovators, and cannabinoid medical professionals to help pioneer the latest and most exciting developments in this rapidly emerging field of medicine to the forefront of the general practice.

Education and Research

The MCCS is an independent community of Medical Cannabis pioneers. An expert-led, non-for-profit community, dedicated to bringing this safe, legal and effective medicine to people living with chronic conditions.

Drug Science is an independent, science-led charity, bringing together leading drugs experts from a wide range of specialisms to carry out ground-breaking research into drug harms and effects. Drug Science engages the public, media, policy makers and academics, equipping them with the knowledge and resources to enact positive change.



AJEM is the first and only American medical authority committed to scientific study of the ECS, and to the evidence-based practice of Endocannabinoid Medicine.

The PCCN is proud to support new paths in medical cannabis education and clinical research at Imperial College London.




The SCC is a nonprofit educational and scientific society of physicians and other healthcare professionals dedicated to advancing research and disseminating knowledge about cannabis for medical use.




Professor Dedi Meiri’s team at the Technion Israel Institute of Technology are global leaders in cannabinoid research and involved in numerous clinical trials and in creating the Cannabis Data Project. Our close collaboration allows us to translate and communicate the latest in research and development straight from the laboratory directly to front line clinicians.

The Sapphire Institute provides a source of online learning for patients and healthcare professionals on treatment with medical cannabis

Advocacy

PLEA advocate for quality of life with medicinal cannabis, enabling patients to access their medicine free from the harms of stigmatisation, geographical inconsistencies and financial barriers. We support research into the safety and efficacy of cannabis-based medicinal products, to enable evidence-based prescription for all.


CPASS are providing support, advocacy and education to patients and healthcare professional considering medicinal cannabis treatments

Set up by parents of children receiving medical cannabis on prescription for complex needs, Medcan provides free resources and educational material on cannabis and the endocannabinoid system and provides information on accessing private prescriptions within the UK and the latest information on law and policies surrounding NHS access.

Policy

The Conservative Drug Policy Reform Group’s (CDPRG) mission is to assemble and present evidence drawn from across the spectrum of medicine, law-enforcement, economics, ethics, criminology and human rights, for the benefit of drug policy-making in the UK.

Technology

Alta Flora aims to empower our community to take control of their healthcare through data and are attempting to solve some of the toughest issues in remote patient engagement and quality of life research.